We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Medical DevicesOrthopaedics

FDA Asks Manufacturers of Hip Replacements To Study Failure Rates

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

In an unusual move, the Food and Drug Administration has ordered all producers of a popular category of artificial hip to undertake studies of the implants, which have been linked to high early failure rates and severe health effects in some patients.

In a telephone interview on Tuesday, Dr. William H. Maisel, the deputy director for science at the F.D.A.’s Center for Devices and Radiological Health, said the order marks the broadest use of the agency’s authority to conduct studies of devices after approval for sale. He also said that the F.D.A. wanted information about the entire category of implants, not any single manufacturer’s device.

“This is the largest group of studies that we have asked for,” for an approved class of devices, said Dr. Maisel.

Along with the DePuy division of Johnson & Johnson, other major producers of hip implants include Zimmer, Stryker, Biomet and Wright Medical.

Studies Ordered for Makers of Artificial Hips – NYTimes.com

 

More Read

Medical Technology and How Integral it is to Professionals
Baby Boomer’s Guide to Dealing with Knee Problems
What the FDA Is and Isn’t Doing During the Government Shutdown
Healthcare Revolution: Healthcare IoT Possibilities and Challenges
Connectivity Workflows
   

TAGGED:FDAmedical devicesorthopaedics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Core relationship is dual-track recovery where family support improves outcomes only when families m
Supporting a Loved One Through Addiction Recovery
Addiction Recovery
October 13, 2026
Flat editorial illustration: The article's core relationship is that substantial clinical testing of thymosin alpha-1 did not est
Thymosin Alpha-1 Got the Big Trials Most Peptides Never Get
Global Healthcare
October 12, 2026
Flat editorial illustration: The article examines how researchers study tissue repair through growth factors and peptide-based re
How Researchers Study Tissue Repair: From Growth Factors to Peptide-Based Research
Health
October 12, 2026
Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026

You Might also Like

telehealth
eHealthMedical DevicesMobile HealthRemote DiagnosticsTechnology

Despite the Penalties, Physician Visit Innovation Is Progressing

February 25, 2014
wound market growth bar graph
BusinessFinanceMedical DevicesTechnology

Factors Affecting Wound Market Growth Rates

May 21, 2014

NxThera – Vapor Ablation Therapy for BPH

March 16, 2011
Is Telehealth A Viable Solution To The Dentist Shortage?
Medical DevicesMedical InnovationsTechnology

Is Telehealth A Viable Solution To The Dentist Shortage?

October 5, 2017
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?